Lower PSA at 7 months is prognostic for improved overall survival (OS) in metastatic hormone sensitive prostate cancer (mHSPC) treated with ADT with and without docetaxel (D).
暂无分享，去创建一个
R. DiPaola | M. Carducci | M. Kohli | J. Picus | N. Vogelzang | M. Cooney | R. Dreicer | Jorge A. Garcia | Y. Wong | L. Harshman | N. Hahn | M. Eisenberger | M. Hussain | C. Sweeney | D. Jarrard | Glenn Liu | D. Shevrin | Yu‐Hui Chen